JSSH
REGN icon

J. Safra Sarasin Holding’s Regeneron Pharmaceuticals REGN Stock Holding History

J. Safra Sarasin Holding’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$409K Buy
+656
New +$447K 0.01% 583
2025
Q4 		– Sell
-2,303
Closed -$1.29M – 550
2025
Q3 		$1.29M Buy
2,303
+1,741
+310% +$984K 0.02% 269
2025
Q2 		$295K Sell
562
-438
-44% -$244K 0.01% 433
2025
Q1 		$634K Sell
1,000
-2,125
-68% -$1.46M 0.01% 394
2024
Q4 		$2.23M Buy
+3,125
New +$2.62M 0.04% 217

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

J. Safra Sarasin Holding's REGN Position: Q2 2026 in Review

J. Safra Sarasin Holding opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 656 shares worth $409K. The stake represents 0.01% of the portfolio and ranks #583 among its holdings. This is a return to the name: J. Safra Sarasin Holding previously reported a position in REGN as recently as Q3 2025.

J. Safra Sarasin Holding first reported a position in REGN in Q4 2024 and has held it in 5 quarters since. The position peaked at $2.23M in Q4 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • J. Safra Sarasin Holding held 656 shares of Regeneron Pharmaceuticals worth $409K as of Q2 2026.
  • Regeneron Pharmaceuticals was a new J. Safra Sarasin Holding position in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.01% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #583 holding.
  • J. Safra Sarasin Holding first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • J. Safra Sarasin Holding's Regeneron Pharmaceuticals position peaked at $2.23M in Q4 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.